About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 572609, 8 pages
http://dx.doi.org/10.1155/2013/572609
Review Article

A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine

1Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan
2Department of Surgery, School of Medicine, Toho University, 6-11-1 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan
3Department of Pathology, Tokyo Women's Medical University Yachiyo Medical Center, 477-96 Owada-Shinden, Yachiyo 276-8524, Japan
4Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba 260-8717, Japan
5Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

Received 12 October 2012; Revised 25 December 2012; Accepted 25 December 2012

Academic Editor: Jie Chen

Copyright © 2013 Yuji Tada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yuji Tada, Hideaki Shimada, Kenzo Hiroshima, and Masatoshi Tagawa, “A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine,” BioMed Research International, vol. 2013, Article ID 572609, 8 pages, 2013. doi:10.1155/2013/572609